Felix Benjamin Warwas

Felix Benjamin Warwas is a Physician Scientist at the University of Bonn's Department of Oral and Maxillofacial Plastic Surgery within the Faculty of Medicine. He has been working as an Assistant Doctor (Assistenzarzt) at the Universitätsklinikum Bonn since January 2017 and is affiliated with Nils Heim's Lab.

His educational background includes medical studies at:

• Yeshiva University (April 2016 - June 2016)
• Ruhr University Bochum (October 2015 - February 2021)
• Jagiellonian University (September 2014 - March 2015)

Dr. Warwas specializes in Oral and Maxillofacial Pathology, Craniomaxillofacial Surgery, and Bone Pathology, with particular expertise in the microbiology of dental infections and applications of next-generation sequencing. His research bridges clinical practice and molecular diagnostics, focusing on improving pathogen identification in odontogenic abscesses and understanding microbial resistance patterns. He has also explored the intersection of artificial intelligence and medical education through studies evaluating GPT-4's performance in oral and maxillofacial surgery board exams.

His publication record shows a consistent trajectory of research focused on improving diagnostic accuracy and treatment protocols in maxillofacial conditions, with recent work emphasizing molecular approaches to traditional clinical problems. The publications demonstrate expertise spanning from basic microbiology to clinical outcomes research and educational technology applications.

His scientific recognition includes:

• Scholarship from the NRW Excellence Initiative (June 2012)

Dr. Warwas collaborates extensively within the Department of Oral and Maxillofacial Plastic Surgery at the University of Bonn, working with colleagues including Valentin Wiedemeyer, Nils Heim, Anne Klausing, and others. His work appears to focus on both clinical research and practical applications that directly impact patient care in maxillofacial surgery and dentistry.

His laboratory work within Nils Heim's research group appears to focus on molecular diagnostics for dental infections, bone pathology analysis, and innovative approaches to medical education assessment.